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Abstract
The KIR genes and their HLA class I ligands have thus far not been investigated in pemphigus foliaceus (PF) and related
autoimmune diseases, such as pemphigus vulgaris. We genotyped 233 patients and 204 controls for KIR by PCR-SSP. HLA
typing was performed by LABType SSO reagent kits. We estimated the odds ratio, 95% confidence interval and performed
logistic regression analyses to test the hypothesis that KIR genes and their known ligands influence susceptibility to PF. We
found significant negative association between activating genes and PF. The activating KIR genes may have an overlapping
effect in the PF susceptibility and the presence of more than three activating genes was protective (OR=0.49, p=0.003). A
strong protective association was found for higher ratios activating/inhibitory KIR (OR=0.44, p=0.001). KIR3DS1 and HLA-
Bw4 were negatively associated to PF either isolated or combined, but higher significance was found for the presence of
both together (OR=0.34, p,10
23) suggesting that the activating function is the major factor to interfere in the PF
pathogenesis. HLA-Bw4 (80I and 80T) was decreased in patients. There is evidence that HLA-Bw4(80T) may also be
important as KIR3DS1 ligand, being the association of this pair (OR=0.07, p=0.001) stronger than KIR3DS1-Bw4(80I)
(OR=0.31, p=0.002). Higher levels of activating KIR signals appeared protective to PF. The activating KIR genes have been
commonly reported to increase the risk for autoimmunity, but particularities of endemic PF, like the well documented
influence the environmental exposure in the pathogenesis of this disease, may be the reason why activated NK cells
probably protect against pemphigus foliaceus.
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Introduction
Pemphigus is a group of blistering autoimmune diseases of the
skin that can be subdivided in two major clinical types: pemphigus
foliaceus (PF) and pemphigus vulgaris (PV). The target of the
autoantibodies differs between these two subtypes: while in PF the
antibodies are directed to desmoglein 1 (dsg1), in PV they are
direct to desmoglein 3 or to both desmoglein 1 and desmoglein 3
[1]. Endemic in Brazil, PF was first reported in this country in
1903, when it was thought to be a variant of a superficial mycosis
[2]. PF represents a health problem in Brazil with an incidence of
25–35 million/cases/year. The highest prevalence of 3.4% was
reported for the Terena Amerindian population that sums a total
of about 1,200 individuals, in southern Mato Grosso do Sul State
[3]. This disease manifests usually in rural workers and other low-
wage earners who live near rivers and are exposed to poor living
conditions [4]. The anti-dsg1 antibodies in PF (mainly of the IgG4
subclass) recognize epitopes of the amino-terminal domains of the
extracellular portion of desmoglein 1 [5], affecting the intercellular
junction. The epidermal cell detachment (acantholysis) produces
blistering lesions that may appear as localized or generalized
forms, being a suffering and painful disease.
The etiology of PF is still unclear. As a multifactorial disease,
there are environmental and genetic factors. The first genetic
association with PF was reported in 1989 by our group [6] and was
corroborated by further studies [7] that showed the importance of
the HLA-DR and HLA-DQ genes in the susceptibility to PF. The
polymorphism of other genes, as those coding for cytokines [8],
desmoglein 1 [9], CTLA4 [10,11] CD40L, CD40, BLYS and CD19
[12] has also been analyzed.
NK cells are important for the immune response, and are
controlled by activating and inhibitory receptors. The killer-cell
immunoglobulin-like receptors (KIR) and their cognate HLA class
I ligands are crucial for NK regulation [13]. The ligands of several
inhibitory (2DL and 3DL) and activating (2DS and 3DS) KIR
have been described. The KIR2DL1 recognizes HLA-C2 while
KIR2DL2 and 2DL3 recognize the allotypes of HLA-C named
C1 and a few C2 allotypes [14]. KIR2DS1 exhibits weak
recognition for HLA-C2 and KIR2DS2 appears not to recognize
any HLA epitope [15,16]. KIR3DL1 binds the epitope Bw4, that
comprises about 40% of the HLA-B allotypes and some of the
HLA-A molecules (A*23, A*24, A*25 and A*32) [17]. The Bw4
positive HLA-A molecules and also a subset of the HLA-B Bw4
molecules that have isoleucine at position 80 (Bw4-80I) showed
PLoS ONE | www.plosone.org 1 July 2012 | Volume 7 | Issue 7 | e39991stronger interaction with KIR receptors than Bw4-80T (threonine)
[18,19]. Despite HLA-B epitopes are currently regarded as the
most important KIR3DL1 ligands, we recently suggested that both
HLA-A and HLA-B allotypes may be equally important for NK
cell function [20]. Moreover, it has been suggested that KIR3DS1
also interacts with Bw4 molecules [21], even with no direct
evidence.
Natural killer (NK) cells may play an important role in
autoimmune diseases of the skin [22]. Takahashi et al. [23]
showed that a higher percentage and number of NK cells are
present in the peripheral blood of PV patients. Moreover, the NK
cell of patients exhibited lower levels of perforin and granzime.
Evidences that NK may play a role in the pathobiology of PV were
also reported [24]. KIR polymorphism and combinations KIR/
HLA have been associated with several diseases, including
autoimmune [25], but the importance of NK and KIR in
pemphigus foliaceus has not yet been explored. The aim of this
work was to verify if KIR polymorphism and their known HLA
ligands influence the susceptibility or resistance to PF.
Results
The frequencies of all the KIR genes analyzed in patients and
controls are listed in Table S1. The absence/presence polymor-
phism of KIR2DS1, KIR2DS3, KIR3DS1 and KIR2DL5 was found
negatively associated with PF, while KIR3DL1 was positively
associated to the disease in Euro-descendants (Table 1). As
extensively known, KIR haplotypes are subdivided in two major
haplogroups (A and B), being the A haplogroup characterized by
the presence of only KIR2DS4 as classic activating gene [26]. We
found that the A/A genotype is associated to a higher susceptibility
to PF and that the presence of B haplotypes is protective (Table 2).
The number of inhibitory and of activating genes was compared
between patients and controls. The function of KIR2DL4 is
controversial, since it has an inhibitory motif (ITIM) in the
intracellular domain [27] and an arginine in the transmembrane
domain, putatively responsible for activating function [28]. It has
been reported that the predominant function of KIR2DL4 is
activating [28,29] and for that reason, this gene was considered as
activating in our analyses. No protein product or ligand was
reported for the KIR3DL3 gene thus far [30]. Therefore, this gene
was removed from our analyses, considering that its function is still
obscure. The deleted form of KIR2DS4 was counted neither as
activating nor as inhibitory. We found a significant association for
the presence of more than three activating genes (OR =0.49, 95%
CI =0.30–0.79, p=0.003), which also means an odds ratio of
2.08 (95% CI =1.25–3.32) for the presence of three or less
activating genes (Figure 1A). For inhibitory genes, no statistical
differences were found (Figure 1B). Further, we analyzed the ratio
activating/inhibitory genes; the frequencies are shown in
Figure 1C. A strong negative association was found for the ratio
equal or higher than 0.75 (OR =0.44; 95% CI =0.27–0.73;
p=0.001).
The model tested in regression analyzes was performed only in
the Euro descendants sample and it included the follow
components: Presence of each of the negatively associated genes
(KIR2DS1, KIR2DS3, KIR3DS1 and KIR2DL5), presence of HLA
ligands (Bw4, C1 and C2), the presence of A/A or B/x haplotypes,
the presence of more than three activating genes and the
occurrence of activating/inhibitory genes ratio equal or higher
than 0.75. The logistic regression analysis showed that the
presence of more than three activating genes alone explained
the result (OR =0.25, 95% CI =0.13–0.49, p,10
23, log
likelihood =195.502).
The frequent deletion of 22 pb in a group of KIR2DS4 alleles
reported by Hsu et al. [31] generates a truncated protein with no
transmembrane and cytoplasmic domains not expressed on the
cell surface. We investigated if this deletion, and consequently the
loss of the KIR2DS4 activating function, interferes in PF
susceptibility, and no significant result was found (p.0.05).
We analyzed all known HLA class I KIR ligands (Table 3). The
presence of one or more Bw4 epitopes (Bw4 80T and Bw4 80I
from the HLA-A or HLA-B loci) was negatively associated (OR
=0.45, p=0.005). Bw4 80T was also associated to protection
against the disease (OR =0.37, p=0.001) but we did not find any
association for Bw4 80I individually. We observed a strong and
positive association for the presence of Bw6 (OR =4.28, p,10
23).
We also analyzed the association between individuals who present
only Bw4 epitopes, individuals carrying both Bw4 and Bw6 and
individuals carrying only Bw6. For these analyses, we considered
Table 1. Genetic association between pemphigus foliaceus and five KIR genes.
Gene Patients Controls
n F (%) n F(%) P OR CI
2DS1 Euro 45 (143) 31.5 65 (131) 49.6 0.002 0.46 0.28–0.76
Afro 35 (90) 38.9 31 (72) 43.1 0.590 0.84 0.44–1.58
2DS3 Euro 27 (144) 18.8 44 (130) 33.8 0.004 0.45 0.26–0.78
Afro 30 (89) 33.7 20 (73) 27.4 0.386 1.34 0.68–2.65
3DS1 Euro 42 (142) 29.6 58 (131) 44.3 0.011 0.54 0.33–0.89
Afro 36 (89) 40.4 28 (73) 38.4 0.791 1.09 0.58–2.06
2DL5 Euro 65 (144) 45.1 81 (130) 62.3 0.004 0.49 0.30–0.87
Afro 55 (89) 61.8 41 (75) 54.7 0.356 1.34 0.72–2.50
3DL1* Euro 135 (144) 93.8 116 (131) 88.6 0.126 1.93 0.81–4.60
Afro 84 (89) 94.4 64 (73) 87.7 0.130 2.35 0.75–7.39
In parentheses, the total number of individuals in the sample. Only genes which presented significant (P,0.05) association in at least one population sample are shown.
The frequencies of all KIR genes are presented in Table S1.
Euro: predominantly European background; Afro: mixed subsample, with predominantly African background.
*For the total sample (combining the Euro and Afro populations) we found a significant association for KIR3DL1: OR =2.1, 95% CI 1.05–4.14, p=0.033.
doi:10.1371/journal.pone.0039991.t001
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absence of dominance and epistasis (only Bw4: OR=0.24,
p,10
23; both Bw4 and Bw6: OR =0.61, p=0.05; only Bw6:
OR =1.92, p=0.03). Next, we tested if the Bw4 epitopes were in
linkage disequilibrium (LD) with HLA class II alleles associated to
PF reported by Pavoni et al. (2003). In that study, the authors
separated the HLA-DRB1 alleles in three groups: susceptibility,
neutral and protective. We found that LD between the suscepti-
bility group of HLA-DRB1 alleles and Bw4(80T) is negative (D’
=21.00, p=0.001). Bw4(80I) was also in negative LD with this
group of HLA alleles (D’ =20.47, p=0.001) while LD with Bw6
was positive (D’ =0.59, r
2=0.13 and p,10
23).
The KIR x HLA combinations were analyzed and are shown in
Figure 2 and Table S2. We found negative associations for
combinations including KIR3DL1/S1 and Bw4 ligands. We did not
find any association for KIR2DL1, KIR2DL2/3 and KIR2DS1
combined with their HLA-C ligands (data not shown).
Discussion
In this study we describe the KIR gene frequencies in an urban
population living in Western Brazil (Table S1) and, for the first
time, we show a genetic association between susceptibility to
pemphigus foliaceus and KIR genes and their HLA ligands.
All negatively associated genes (KIR2DS1, KIR2DS3, KIR3DS1
and KIR2DL5– Table 1) are not present in haplotype A, what
could indicate, at first moment, that the presence of the B
haplotype and not of each isolated gene, may protect against PF.
In fact, we found a genetic association for the presence of B
haplotypes (Table 2). In addition, we analyzed all pairs of
associated genes for the presence of both, presence of one or the
other and the absence of both (data not shown). Based on this, we
hypothesized that the activating KIR could exhibit an additive
effect for PF protection. Considering that combinations of several
activating genes are typically found in B haplotypes [26], we
hypothesized that the KIR activating function, rather than the
isolated receptors, could be the cause of the differential
susceptibility. Counting the number of activating genes in each
individual, it became clear that the presence of a higher number of
activating genes has a protective effect (Figure 1A). As expected by
this hypothesis, the number of inhibitory genes did not differ
significantly between patients and controls (Figure 1B). It is
consensus that the balance of activating and inhibitory signals has
a major effect on NK cell function [32]. Bearing that in mind, we
evaluated the ratio activating/inhibitory genes (Figure 1C) and a
stronger negative association was found (OR =0.44 p=0.001).
These results point to an at least partially redundant function
among the activating genes and they may be all equally involved in
PF protection. This hypothesis was corroborated by the regression
analyzes, which showed the presence of more than three activating
genes as the major factor of differential susceptibility. A similar
conclusion was also reported by van der Slik et al., [33] who
extensively tested many regression models in type 1 diabetes,
showing that activating KIR genotypes influence the overall
hierarchy of protection or susceptibility. Although the regression
analyzes point the presence of more than three genes as the major
factor for susceptibility to PF, it is important to remember that this
analyze does not consider other KIR receptors. Considering the
balance of signals as the possible major responsible for modulating
the NK response [32], the ratio activating/inhibitory genes may
be the most important factor if all NK receptors could be analyzed
together.
A summary of case/control studies of KIR and KIR+HLA
combinations in autoimmune diseases are shown in Table 4. In
general, the activating KIR genes seem to increase the autoimmune
response, being regarded as susceptibility factors in several studies.
However, the interactions among NK cell receptors and HLA
ligands may play a different role in the different diseases.
The importance of NK cell in autoimmunity mediated by B cell
has been studied, [34] showing that NK activation can result in
altered antibody responses, including those against autoantigens.
Many autoimmune diseases are suspected to be related with
infectious etiology, what brings the NK cell, responsible for the
first line of defense, to an important role in the protection against
autoimmunity. Particularities of PF could explain why the
activating KIR function is protecting against this disease. Different
from other autoimmune diseases, PF presents extremely high
incidence in some endemic geographical areas in Brazil, in sharp
contrast to its very low incidence elsewhere in South America and
other continents. This unusual characteristic and also the gradual
replacement of the endemic area in Brazil beyond years show that
one (or more) environmental factor of limited geographic
distribution is triggering the disease. Although the exact nature
of the environmental contribution is still obscure, there are
evidences that a black fly from the Simuliidae family could be
involved in the infection with a protein, a virus or a microorganism
which could initiate the autoimmune response in genetic
susceptible individuals [35]. This agent does not need to result
in an overt disease in the exposed individuals but it is related to the
onset of pemphigus foliaceus. Moreover, other factors are also
associated to PF, such as the low quality of life, the vicinity to
rivers, some food, among others [4]; and the patients are usually
exposed to this environmental context during their entire life.
Many association studies have demonstrated that activating KIR
genes protect against infectious disease (reviewed by Kulkarni et
al., 2008 [25]). Therefore, carrying more activating KIR genes
could represent a better protection against viruses, microorganisms
or other environmental factors that trigger PF. Increasing the
Table 2. The A/A genotype is associated to increased susceptibility to pemphigus foliaceus.
Genotypes Patients Controls
n F (%) n F(%) P OR 95% CI
A/A Euro 50 (145) 34.5 27 (134) 20.1 0.007 2.08 1.21–3.60
Afro 25 (90) 27.8 18 (72) 25.0 0.689 1.15 0.57–2.34
B/x Euro 95 (145) 65.5 107 (134) 79.9 0.007 0.48 0.28–0.83
Afro 65 (90) 72.2 54 (72) 75.0 0.689 0.87 0.43–1.75
In parentheses, the total number of individuals in the sample. B/x indicates A/B or B/B genotypes. Euro: predominantly European background; Afro: mixed subsample,
with predominantly African background; Total: total sample.
doi:10.1371/journal.pone.0039991.t002
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receptors recognizing antigens and activating the NK to defense.
Schleinitz et al. [36] presented other hypotheses on the reasons
why NK cells could protect against autoimmunity. They could
control the presentation of autontigens by killing the immature
dendritic cells or control the activation of macrophages, which are
responsible for tissue injury in chronic inflammation. However, in
this particular disease, the activation of NK cells that control the
release of autoantigens, mainly by regulating the environmental
factors, such virus or other pathogens, could explain why the
activating KIR function may be protective.
Only two inhibitory genes differed between patients and
controls. KIR3DL1 was associated to increased susceptibility
(OR =2.1; p=0.03) in the total sample. Because the odds ratios
indicated increased susceptibility in both strata (Euro, OR =1.93;
Afro, OR =2.35) we merged the two samples for KIR3DL1
association analysis This association could be explained by the
absence of KIR3DS1, once 3DL1 and 3DS1 are alleles of the same
locus. The presence of KIR3DL1 (and consequently the absence of
KIR3DS1), may generate an increase of inhibitory signals, with
reduction of the ratio activating/inhibitory receptors, what could
explain this association. On the other hand, the haplotype B gene
KIR2DL5 was negatively associated to PF in Euro-descendants
only. We conclude that this association results from the linkage
disequilibrium with several activating genes that are associated to
PF only in this population stratum. High positive LD values for the
pairs KIR2DL5 and other haplotype B activating genes (2DS3,
2DS5) are well recognized and have been reported in many
studies, including a Southern Brazilian population of similar
ancestry as our study population [20].
The different association patterns between Euro-descendant and
Afro-descendant samples could be consequences of the complexity
of the disease, allied to differences of other interacting susceptibility
factors, whose frequencies may differ between the two population
strata. The functional effects of the gene products depend on
complex pathways. Other unknown genetic and environmental
factors related to PF susceptibility may be involved in complex
interactionswiththegeneshereanalyzed,andmaydependpartially
on the ethnic context. Among all factors involved in resistance or
susceptibility to PF, the activating KIR relative effect in Euro-
descendants is possibly higher, which means that other unknown
factors may predominate in this disease in Afro-descendants.
The frequency of HLA-C1/C2 did not differ between patients
and controls, but significant associations were found regarding the
Bw4 ligands (Table 3). It is noteworthy that, besides the differential
susceptibility to PF being strongly associated with HLA class II
genes [6,7], this is the first study reporting significant association
between this disease and the class I genes. The Bw4 epitope was
found negatively associated with PF, in agreement with the
negative association observed for its cognate activating KIR3DS1
receptor. Therefore, the susceptibility conferred by the presence of
Bw6 could be interpreted, in this context, as simple consequence of
the absence of Bw4. It is also corroborated by the effect of absence
of dominance found between Bw4 and Bw6 epitopes. We cannot
discard, however, the possibility of Bw6 acting in a direct
susceptibility role. Due its weak binding to its receptor, [18,19]
the stronger association of Bw4(80T) than Bw4(80I) could be an
evidence that the KIR binding is not the only reason for this
epitope being associated. Although we do not know if HLA-A and
B have other implications in PF pathogeneses beyond KIR
recognition, a careful search for allelic association of these loci
should be performed.
To verify if the association between PF and the HLA Bw4 and
Bw6 epitopes could result from LD with the previously associated
HLA-DRB1 alleles, we analyzed the linkage disequilibrium
between these class I and class II genes. Interestingly, Bw4(80T),
which is significantly less frequent among patients than among
controls, was found in negative LD with the protective group of
Figure 1. Frequency of the number of activating and inhibitory KIR genes in patients and controls. Only the Euro population was
considered. (A) KIR2DL4 was counted as activating gene and the deleted KIR2DS4 was not counted as activating or inhibitory. Significant negative
association was found for the presence of more than 3 activating genes (OR =0.49; 95% CI=0.30–0.79; p=0.003). (B) KIR3DL3 was not included as
inhibitory. (C) Significant negative association was found for the ratio higher than 0.75 (OR =0.44; 95% CI =0.27–0.73; p=0.001).
doi:10.1371/journal.pone.0039991.g001
Table 3. Association analyzes between pemphigus foliaceus and HLA ligands of KIR.
KIR Ligands Patients Controls
n f (%) n F(%) P OR 95% CI
Bw4* Euro 64 (99) 64.6 56 (71) 78.9 0.045 0.49 0.24–0.99
Afro 42 (64) 65.6 35 (42) 83.3 0.045 0.38 0.15–0.99
Total 106 (163) 65.0 91 (113) 80.5 0.005 0.45 0.26–0.79
Bw4 80I Euro 57 (99) 57.6 47 (72) 65.3 0.307 0.72 0.38–1.35
Afro 38 (64) 59.4 30 (42) 71.4 0.210 0.58 0.25–1.34
Total 95 (163) 58.3 77 (114) 67.5 0.110 0.45 0.41–1.11
Bw4 80T Euro 15(98) 15.3 16 (66) 24.2 0.144 0.56 0.25–1.22
Afro 5 (61) 8.2 14 (41) 34.2 0.001 0.17 0.06–0.53
Total 20 (159) 12.6 30 (107) 28.0 0.001 0.37 0.20–0.69
Bw6 Euro 91 (96) 94.8 57 (66) 86.4 0.060 2.87 0.92–9.01
Afro 58 (61) 95.1 30 (41) 73.2 0.001 7.09 1.84–27.04
Total 149 (157) 94.9 87 (107) 81.3 ,10
23 4.28 1.81–10.13
In parentheses, the total number of individual in the sample. Euro: predominantly European background; Afro: mixed subsample, with predominantly African
background; Total: total sample. *at least one Bw4 epitope (80I from HLA-A or HLA-B loci or 80T).
doi:10.1371/journal.pone.0039991.t003
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associated to higher susceptibility to PF and occurs in positive LD
with the susceptibility group of HLA-DRB1 alleles. We cannot
affirm that the association found for Bw4 and Bw6 is simply a
consequence of the LD with HLA class II alleles or vice versa, but
this is possible. The associations of pemphigus foliaceus with Bw4
and with HLA-DRB1 might both result from their functions.
Differential epitope selection by the HLA-DRB1 molecules
encoded by different alleles is a likely mechanism, but we still do
not know if this is the cause of the associations, because of the lack
of functional studies. Similarly, it is plausible to hypothesize that
the Bw4 epitope has a direct influence on pemphigus foliaceus
disease susceptibility, because of its importance for recognition by
KIR; however, this remains to be formally demonstrated by
functional studies. Notwithstanding, the fact that the association
between PF and the combination of KIR genes with their cognate
HLA ligands is stronger that the associations with the receptors
and the ligands individually is an compelling evidence that the
interaction of Bw4 by its KIR receptor is directly involved in PF
pathogenesis.
Combinations KIR+HLA also exhibited significant differences
between patients and controls (Figure 2). The presence both
KIR3DS1 and Bw4 showed stronger association than each one
separately, which may corroborate that the activating function
may be, in fact, the major factor interfering in the PF pathogenesis.
Interestingly, the strongest negative association between KIR+HLA
combinations was found for KIR3DS1+HLA-Bw4(80T). There are
clear evidences that HLA-Bw4(80I) is powerfully recognized by
KIR3DL1, and only indirect evidences that its homologue
KIR3DS1 interacts with the same ligand [18,19,21]. Nevertheless,
the isoleucine at position 80 is not essential for this interaction [37]
and the studies performed have regarded mainly KIR3DL1
activity, being the comparisons between the KIR3DS1 ability of
distinguishing both Bw4 ligands not well explored. These findings
show that Bw4(80T) may also be important as a KIR3DS1 ligand,
even if they are less strongly recognized.
KIR activating genes, their HLA ligands and combinations of
both appear to be protective in the context of PF etiology. This
association may be related with the contribution of infectious
agents to the pathogenesis of this disease. NK cells have been
demonstrated as important for autoreactivity and also have been
implicated in several autoimmune diseases. To understand how
those cells and their receptors influence the immune response
could be a key for the comprehension of one face of the
autoimmune complexity.
Materials and Methods
We analyzed 233 patients and 204 controls without history of
the disease. The majority of the patients were contacted at
Hospital Adventista do Pe ˆnfigo, Campo Grande, MS, Brazil. All
individuals voluntarily agreed to participate and provided written
informed consent. This study was approved by the Human
Research Ethics Committee of the Federal University of Parana,
in accordance with the Brazilian Federal laws. The individuals
were separated in two groups, according to their predominant
ancestry: Euro-descendants (Euro) and Afro-descendants (Afro).
The reason of this subdivision is because different populations may
differ in allele frequencies. Although this subdivision is arbitrary,
this approach was validated by population genetic studies, which
showed that the distribution of alleles known to be restricted to
populations autochthonous from one continent follows a gradient
among the population strata, as expected if the classification
discriminated the strata according to relative contributions of the
ancestral population [38,39]. When the frequencies between Euro-
descendants and Afro-descendants did not differ statistically, they
were analyzed as a single population sample, because the total
sample may give us a better representation of the whole
population.
The KIR genotyping was performed by the PCR-SSP multiplex
method [40] using two pairs of primers for each gene. For
KIR2DL2 and 2DL3, an additional pair of primers for each gene
[41] was included to confirm the results. A subset (163 patients and
114 controls) was genotyped for HLA class I applying the
LABTypeH SSO reagent kits (One Lambda, USA).
Frequencies of KIR genes and haplogroups were obtained by
direct counting. Tests of population differentiation were per-
formed by analyzes of 262 contingency tables, calculating the
exact p value by the metropolis algorithm. The p value of 0.05 was
adopted as the significance limit. The Mantel-Haenszel method
[42] applied for calculating the odds ratio (OR) and the 95%
confidence intervals. Logistic regression analyzes were carried out
Figure 2. Association analyzes for the combinations KIR x HLA ligands. The bars indicate the 95% confidence interval and the black spot
indicates the OR. The results for the Euro sample are shown. The results for the two population strata and the complete information about KIR and
HLA combinations are found in Table S2. *at least one Bw4 epitope (80I from HLA-A or HLA-B loci or 80T).
doi:10.1371/journal.pone.0039991.g002
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were obtained using the ELB algorithm and the estimates of the
LD parameters D9,r
2, and p value were performed using the
Arlequin software package [43].
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